You can buy or sell GEMP and other stocks, options, ETFs, and crypto commission-free!
Gemphire Therapeutics Inc. Common Stock, also called Gemphire Therapeutics, is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics of dyslipidemia, as well as non-alcoholic fatty liver disease. Read More It offers a small molecule formulated as a tablet product under the Gemcabene brand. The company was founded by Charles L. Bisgaier and David Lowenschuss on October 30, 2014 and is headquartered in Livonia, MI.
52 Week High
52 Week Low
-$0.41 per share
-$0.26 per share